Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials.

Saved in:
Bibliographic Details
Title: Olanzapine plus triple antiemetic therapy for prevention of carboplatin-induced nausea: a pooled analysis of two clinical trials.
Authors: Kojima S; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Inui N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan. inui@hama-med.ac.jp.; Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu, Japan. inui@hama-med.ac.jp., Suzuki T; Department of Respiratory Medicine, Hamamatsu Medical Center, Hamamatsu, Japan., Tanaka K; Department of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan., Karayama M; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Inoue Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Yasui H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Hozumi H; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Suzuki Y; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Furuhashi K; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Fujisawa T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Enomoto N; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan., Nishimoto K; Department of Respiratory Medicine, Iwata City Hospital, Iwata, Japan., Matsuura S; Department of Respiratory Medicine, Fujieda Municipal General Hospital, Fujieda, Japan., Hashimoto D; Department of Respiratory Medicine, Seirei Hamamatsu General Hospital, Hamamatsu, Japan., Matsui T; Department of Respiratory Medicine, Seirei Mikatahara General Hospital, Hamamatsu, Japan., Asada K; Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan., Suda T; Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu, Japan.
Source: BMC cancer [BMC Cancer] 2025 Oct 01; Vol. 25 (1), pp. 1494. Date of Electronic Publication: 2025 Oct 01.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Clinical Trial, Phase II
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1471-2407
DOI:10.1186/s12885-025-14985-1